RAF1 and cancer: vMCF-7∆Raf1 cells showed higher resistance to the genotoxic agent DR compared to MCF-7 cells, corroborating the causal role of Raf/MAPK oncogenic signaling in promoting resistance to conventional anti-cancer drugs [46].